X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (154) 154
humans (137) 137
animals (79) 79
mice (52) 52
hematology (41) 41
sialic acid binding ig-like lectin 2 - antagonists & inhibitors (36) 36
antibodies, monoclonal - therapeutic use (30) 30
female (30) 30
immunology (30) 30
cell line, tumor (29) 29
oncology (29) 29
sialic acid binding ig-like lectin 2 - immunology (28) 28
cd22 (24) 24
immunotherapy (24) 24
male (24) 24
abridged index medicus (22) 22
ligands (22) 22
cancer (21) 21
chemotherapy (21) 21
biochemistry & molecular biology (20) 20
sialic acid binding ig-like lectin 3 (19) 19
article (18) 18
expression (18) 18
sialic acid binding ig-like lectin 2 - metabolism (18) 18
b-lymphocytes - immunology (17) 17
antigens, cd - immunology (16) 16
antineoplastic agents - therapeutic use (16) 16
flow cytometry (16) 16
gemtuzumab ozogamicin (16) 16
lectins (16) 16
medicine, research & experimental (16) 16
research (16) 16
analysis (15) 15
antineoplastic agents - pharmacology (15) 15
b-lymphocytes - drug effects (15) 15
binding (15) 15
immune system (15) 15
leukemia (15) 15
leukemia, myeloid, acute - drug therapy (15) 15
lymphocytes (15) 15
monoclonal-antibody (15) 15
sialic acid binding ig-like lectin 3 - antagonists & inhibitors (15) 15
sialic acid binding ig-like lectin 3 - metabolism (15) 15
adult (14) 14
antigens, cd - metabolism (14) 14
cell biology (14) 14
gene expression (14) 14
leukemia, myeloid, acute - metabolism (14) 14
monoclonal antibodies (14) 14
acute myeloid leukemia (13) 13
antibodies, monoclonal - pharmacology (13) 13
antibodies, monoclonal, humanized - pharmacology (13) 13
antibodies, monoclonal, humanized - therapeutic use (13) 13
apoptosis (13) 13
cd22 antigen (13) 13
in-vivo (13) 13
proteins (13) 13
rituximab (13) 13
therapy (13) 13
acute myeloid-leukemia (12) 12
care and treatment (12) 12
research article (12) 12
b cells (11) 11
leukemia, myeloid, acute - genetics (11) 11
molecular targeted therapy (11) 11
receptor (11) 11
sialic acids (11) 11
signal transduction (11) 11
activation (10) 10
b-cells (10) 10
cells (10) 10
clinical trials as topic (10) 10
health aspects (10) 10
hemic and lymphatic diseases (10) 10
immunoglobulins (10) 10
leukemia, myeloid, acute - immunology (10) 10
lupus erythematosus, systemic - drug therapy (10) 10
myelin-associated glycoprotein (10) 10
protein binding (10) 10
receptors (10) 10
siglecs (10) 10
signal transduction - drug effects (10) 10
treatment outcome (10) 10
acute lymphoblastic leukemia (9) 9
aged (9) 9
antibodies (9) 9
antigens, cd20 - immunology (9) 9
autoimmune diseases (9) 9
chemistry, medicinal (9) 9
identification (9) 9
macrophages (9) 9
mice, inbred c57bl (9) 9
mice, knockout (9) 9
molecular sequence data (9) 9
non-hodgkins-lymphoma (9) 9
organic acids (9) 9
sialic acid binding ig-like lectin 2 (9) 9
sialic acid binding ig-like lectin 3 - genetics (9) 9
sialic acid binding ig-like lectin 3 - immunology (9) 9
sialic acid binding immunoglobulin-like lectins (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 2015, Volume 100, Issue 3, pp. 336 - 344
Journal Article
Human Gene Therapy, ISSN 1043-0342, 05/2018, Volume 29, Issue 5, pp. 626 - 639
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0166891 - e0166891
Background Approximately fifty percent of patients with acute myeloid leukemia can be cured with current therapeutic strategies which include, standard dose... 
GEMTUZUMAB OZOGAMICIN | PHARMACOKINETICS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | IMMUNOGLOBULIN | DEATH | ON-TARGET | CASPASE-9 | INDUCED KILLER-CELLS | SAFETY SWITCH | LYMPHOCYTES | Recombinant Fusion Proteins - immunology | Cyclophosphamide - analogs & derivatives | Caspase 9 - genetics | Humans | Sialic Acid Binding Ig-like Lectin 3 - immunology | Leukemia, Myeloid, Acute - immunology | Cellular Reprogramming | Biphenyl Compounds - pharmacology | Lysosomal-Associated Membrane Protein 1 - genetics | Nitrophenols - pharmacology | Myeloid Cells - immunology | T-Lymphocytes - drug effects | Lysosomal-Associated Membrane Protein 1 - immunology | Tumor Necrosis Factor-alpha - immunology | Myeloid Cells - drug effects | Receptors, Antigen, T-Cell - immunology | Leukemia, Myeloid, Acute - therapy | Sialic Acid Binding Ig-like Lectin 3 - genetics | Leukemia, Myeloid, Acute - pathology | Clinical Trials as Topic | Sulfonamides - pharmacology | Piperazines - pharmacology | Caspase 9 - immunology | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | T-Lymphocytes - cytology | B7-H1 Antigen - pharmacology | Cyclophosphamide - pharmacology | Interferon-gamma - immunology | Sialic Acid Binding Ig-like Lectin 3 - antagonists & inhibitors | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Cell Engineering | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Receptors, Antigen, T-Cell - genetics | Myeloid Cells - pathology | Primary Cell Culture | Genetic Vectors | Tumor Necrosis Factor-alpha - biosynthesis | Interferon-gamma - biosynthesis | Cytotoxicity, Immunologic | Leukemia, Myeloid, Acute - genetics | Usage | Transplantation | Research | T cells | Immunotherapy | Stem cells | Transplants & implants | Bcl-2 protein | Leukemia | Mental health | Oncology | Standard error | Lymphocytes T | Suicide | Hematopoietic stem cells | Infusion | Immunology | Granulocytes | Lymphocytes | Drug dosages | Genetic modification | Suicide genes | Antigens | Cytokines | Risk groups | Hematology | Myeloid leukemia | Safety measures | Risk reduction | T cell receptors | Tumor necrosis factor-α | Patients | Hemopoiesis | Studies | Chemotherapy | Inhibitors | γ-Interferon | Degranulation | Antitumor activity | Ligands | Interferon | Gene therapy | Acute myeloid leukemia | Cancer | Apoptosis | Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 28, pp. 43281 - 43294
Journal Article
Biomaterials, ISSN 0142-9612, 06/2018, Volume 167, pp. 132 - 142
Journal Article
Blood, ISSN 0006-4971, 12/2017, Volume 130, Issue 23, pp. 2469 - 2474
In 2017, 4 drugs received US Food and Drug Administration marketing approval for acute myeloid leukemia (AML) treatment: targeted therapies for mutant FLT3 and... 
ADULT PATIENTS | TREATMENT-NAIVE | OLDER PATIENTS | INDUCTION CHEMOTHERAPY | LOW-DOSE CYTARABINE | OPEN-LABEL | ACUTE MYELOID-LEUKEMIA | TRANS-RETINOIC ACID | KINASE INHIBITOR | GREATER-THAN-OR-EQUAL-TO-65 YEARS | HEMATOLOGY | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Triazines - therapeutic use | Humans | Leukemia, Myeloid, Acute - metabolism | Staurosporine - analogs & derivatives | Isocitrate Dehydrogenase - antagonists & inhibitors | Molecular Targeted Therapy | fms-Like Tyrosine Kinase 3 - genetics | Aminopyridines - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Antibodies, Monoclonal, Humanized - pharmacology | Leukemia, Myeloid, Acute - drug therapy | Daunorubicin - administration & dosage | Triazines - pharmacology | Antibodies, Monoclonal, Humanized - therapeutic use | Isocitrate Dehydrogenase - genetics | Treatment Outcome | Clinical Trials as Topic | Sulfonamides - pharmacology | Cytarabine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Sulfonamides - therapeutic use | Staurosporine - therapeutic use | Aminopyridines - pharmacology | Sialic Acid Binding Ig-like Lectin 3 - antagonists & inhibitors | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Liposomes | Mutation | Aminoglycosides - pharmacology | Staurosporine - pharmacology | Aminoglycosides - therapeutic use | Leukemia, Myeloid, Acute - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Experimental Hematology, ISSN 0301-472X, 10/2017, Volume 54, pp. 40 - 50
Journal Article